Colony picking plays a key role in both mammalian cell line development and microbiology research. In recent years, the field has tackled a range of scientific challenges - from advances in CRISPR-based genome editing to the urgent demand for effective therapeutics targeting SARS-CoV-2.
This eBook is designed to support scientists in selecting the right automated colony picking solution. It takes into account the need for high-throughput capabilities, application-specific requirements, and common bottlenecks in the workflow.
The focus is on currently available screening devices for microbial and mammalian clones, with a side-by-side comparison of established technologies to help guide informed decision-making.
Download your copy now to learn more.
Download the eBook
About Molecular Devices UK Ltd
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California, with offices around the globe. For more information, please visit www.moleculardevices.com.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.